News

  1. Medable Is The First Digital Trial Vendor To Achieve Landmark CNIL Approval 3/10/2025

    Learn how Medable’s eConsent and eCOA solutions have been approved for use in two clinical studies in eight countries outside of the European Union by France’s Commission Nationale de l’Informatique et des Libertés (CNIL).

  2. Simbec-Orion And Avance Clinical Consolidates Partnership With Memorandum Of Understanding 3/4/2025
  3. ActiGraph And Hyfe Announce Availability Of New Digital Health Tool For Cough Monitoring 2/25/2025

    PENSACOLA, FL, January 28, 2025 - ActiGraph, the global leader in wearable digital health technology for clinical research and development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their new digital health solution for detection of coughs using the ActiGraph LEAP wearable.

  4. Novotech Releases Comprehensive Report On Oncolytic Virus Therapy 1/30/2025

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, has released its latest report, Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment. 

  5. Novotech Releases Report On Current State Of Triple-Negative Breast Cancer Clinical Trials 1/30/2025

    Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Triple-Negative Breast Cancer (TNBC). The report highlights significant advancements in therapeutic strategies, regional clinical trial activity, and evolving biomarkers driving innovative TNBC treatments. 

  6. Comparing Eye Exams In Mobile Settings To In-Office Exams 1/29/2025

    2020 On-site, a Boston-based mobile optometry company whose mission is to expand access to high-quality vision care including clinical research, has completed its observational study to assess the quality of subjective refraction, autorefraction, and keratometry measurements in a mobile eye setting.

  7. ActiGraph Accelerates Clinical Trial Modernization With Transformational Acquisition Of Biofourmis Life Science Business 1/22/2025

    ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry.  The combined solution will create a market-leading, unified software and data ecosystem for the modernization of clinical research throughout the drug-product lifecycle and across therapeutic areas.

  8. Avance Clinical Leads As The CRO Of Choice For Early Phase Clinical Trials In Australia – Announced At Biotech Showcase 2025 1/14/2025

    Wake Forest, NC, USA | Adelaide, Australia

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for Early Phase clinical trials in Australia with more than 52% of market share. Avance Clinical Australia leads in the active Phase I trials, registered on clinical trial registry ANZCTR (as of 17 December 2024). More than 80% of Avance Clinical clients are US biotechs.

    Book a meeting with the Avance Clinical team at Biotech Showcase.

  9. Novotech Releases Report On Global Parkinson's Disease Clinical Trial Landscape 12/30/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024. This report provides critical insights into the trends, opportunities, and challenges in Parkinson's disease (PD) research, serving as a valuable resource for companies developing treatments for this complex neurodegenerative disorder.

  10. Novotech Named A Fierce CRO Award Winner In The Excellence In Clinical Trial Management And Global Operations Categories 12/30/2024

    Novotech has announced it was named a Fierce CRO Award winner by Fierce Biotech in the Clinical Trial Management and Global Operations categories.